SciFluor Life Sciences garners $30 mln

Cambridge, Massachusetts-based drug discovery company SciFluor Life Sciences, a subsidiary of Allied Minds, has secured $30 million in funding. The investors included Invesco Asset Management, Woodford Investment Management and parent company Allied Minds. Also, the company has appointed Dr. William Koster as chairman of the board.

22 April 2015•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail